A pilot study for hematopoietic stem cell transplantation with post-transplantation cyclophosphamide and anti-thymoglobulin from HLA-mismatched related donor for non-malignant diseases (Halo-NM)
Not Applicable
- Conditions
- on-malignant diseases (bone marrow failure, immunodeficiency, inborn errors of metabolism)
- Registration Number
- JPRN-UMIN000026159
- Lead Sponsor
- ational Center for Child Health and Development
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
1. Effusion with grade 2 or worse at CTCAE ver 4.0 2. Uncontrolled infection 3. Severe psychological disorders 4. Pregnant or suspected pregnancy 5. Not eligible for this study at the discretion of the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of events (acute GVHD grade III or more, graft failure, death) by day 30
- Secondary Outcome Measures
Name Time Method